Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): A narrative review

Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre

“…Although some women continue to use HT [ 16 ], as an alternative to HT, many women also use herbal medicines (HM) [ 17 ] antidepressants [ 17 ], GABAergic agents [ 17 ], clonidine [ 17 ], and non-pharmacological approaches for VMS [ 18 ]. The changing HT evidence and multiple treatment options (including no treatment) have made decision-making more complex [ 19 , 20 ].…”

“…Women are taking a greater role in decisions about managing symptoms [ 21 ]. The consumer’s role seems to dominate the clinician’s when deciding on preferred treatment [ 21 ] but professional guidance is still needed and often sought when evidence of efficacy, safety, and multiple treatment options add to confusion [ 19 , 20 ]. However, the legacy of the WHI studies persists.…”

“…Women’s decision-making processes in managing menopause have been modelled in normal [ 19 ] and surgical menopause [ 20 ]. Existing models suggest decision-making is driven by both internal (e.g.…”

“…individual characteristics, values, attitudes, beliefs and preferences) and external factors (e.g. healthcare provider context, facts and information) [ 19 , 20 ] but these models have limitations. Evidence was collated mainly from cross-sectional studies, with many conducted pre-WHI 2002 [ 19 , 20 ].…”

“…healthcare provider context, facts and information) [ 19 , 20 ] but these models have limitations. Evidence was collated mainly from cross-sectional studies, with many conducted pre-WHI 2002 [ 19 , 20 ]. There are comparatively few recent studies focusing on women in the active process of decision-making [ 24 , 26 ].…”